Clorox Company (The) (NYSE:CLX)‘s stock had its “hold” rating reissued by analysts at Royal Bank Of Canada in a note issued to investors on Sunday. They currently have a $115.00 target price on the stock. Royal Bank Of Canada’s target price would indicate a potential downside of 10.95% from the stock’s previous close.

CLX has been the topic of a number of other reports. Jefferies Group LLC restated a “hold” rating and set a $137.00 target price (up from $136.00) on shares of Clorox Company (The) in a report on Wednesday, August 9th. Zacks Investment Research downgraded shares of Clorox Company (The) from a “buy” rating to a “hold” rating in a report on Monday, July 31st. BidaskClub downgraded shares of Clorox Company (The) from a “sell” rating to a “strong sell” rating in a report on Monday, July 24th. BMO Capital Markets restated an “outperform” rating on shares of Clorox Company (The) in a report on Tuesday, September 12th. Finally, Barclays PLC reiterated an “equal weight” rating and issued a $136.00 price objective (down from $140.00) on shares of Clorox Company (The) in a report on Friday, August 4th. Three analysts have rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company’s stock. Clorox Company (The) has an average rating of “Hold” and an average target price of $127.39.

Clorox Company (NYSE:CLX) opened at 129.14 on Friday. The company has a 50-day moving average of $134.59 and a 200-day moving average of $134.61. The firm has a market capitalization of $16.67 billion, a price-to-earnings ratio of 24.21 and a beta of 0.39. Clorox Company has a 1-year low of $111.24 and a 1-year high of $141.76.

Clorox Company (The) (NYSE:CLX) last issued its earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.04. The business had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.65 billion. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The firm’s revenue for the quarter was up 2.9% on a year-over-year basis. During the same period in the previous year, the company earned $1.30 earnings per share. On average, equities analysts predict that Clorox Company will post $5.66 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This report was first reported by Watch List News and is owned by of Watch List News. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this report can be read at https://www.watchlistnews.com/clorox-company-the-clx-stock-rating-reaffirmed-by-royal-bank-of-canada/1616394.html.

In related news, SVP Jon M. Balousek sold 9,223 shares of the company’s stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $138.87, for a total value of $1,280,798.01. Following the transaction, the senior vice president now directly owns 20,614 shares in the company, valued at $2,862,666.18. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Dawn C. Willoughby sold 2,158 shares of the company’s stock in a transaction dated Tuesday, August 29th. The shares were sold at an average price of $138.00, for a total transaction of $297,804.00. The disclosure for this sale can be found here. Insiders sold 21,242 shares of company stock worth $2,944,449 over the last 90 days. 1.00% of the stock is currently owned by corporate insiders.

Several hedge funds have recently added to or reduced their stakes in the stock. Jacobi Capital Management LLC grew its stake in shares of Clorox Company (The) by 0.3% in the first quarter. Jacobi Capital Management LLC now owns 1,282 shares of the company’s stock valued at $172,000 after acquiring an additional 4 shares in the last quarter. Bridgeworth LLC grew its stake in shares of Clorox Company (The) by 0.3% in the first quarter. Bridgeworth LLC now owns 1,869 shares of the company’s stock valued at $252,000 after acquiring an additional 5 shares in the last quarter. Valley National Advisers Inc. grew its stake in shares of Clorox Company (The) by 0.6% in the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock valued at $116,000 after acquiring an additional 5 shares in the last quarter. Bernzott Capital Advisors grew its stake in shares of Clorox Company (The) by 0.4% in the second quarter. Bernzott Capital Advisors now owns 1,607 shares of the company’s stock valued at $214,000 after acquiring an additional 7 shares in the last quarter. Finally, Janney Capital Management LLC grew its stake in shares of Clorox Company (The) by 0.5% in the second quarter. Janney Capital Management LLC now owns 1,611 shares of the company’s stock valued at $214,000 after acquiring an additional 8 shares in the last quarter. Institutional investors and hedge funds own 71.33% of the company’s stock.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.